ADMA Biologics (NASDAQ: ADMA) reported Q2 EPS of ($0.35), versus ($0.55) reported last year. Revenue for the quarter came in at $4.7 million, versus $3.4 million reported last year.

For earnings history and earnings-related data on ADMA Biologics (ADMA) click here.